What is the appropriate treatment for oral and vaginal candidiasis (thrush) in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Thrush (Oral and Vaginal Candidiasis)

For oral thrush with mild disease, use clotrimazole troches 10 mg five times daily for 7-14 days, and for moderate to severe oral thrush, use oral fluconazole 100-200 mg daily for 7-14 days. 1 For uncomplicated vaginal candidiasis, either a single 150 mg dose of oral fluconazole or any topical azole antifungal (clotrimazole, miconazole, terconazole) for 1-7 days depending on formulation are equally effective. 2

Oral Candidiasis (Oral Thrush)

Mild Disease

  • Clotrimazole troches 10 mg five times daily for 7-14 days 1
  • Alternative: Miconazole mucoadhesive buccal 50-mg tablet applied to mucosal surface over canine fossa once daily for 7-14 days 1
  • Alternative: Nystatin suspension (100,000 U/mL) 4-6 mL four times daily, OR 1-2 nystatin pastilles (200,000 U each) four times daily for 7-14 days 1

Moderate to Severe Disease

  • Oral fluconazole 100-200 mg daily for 7-14 days 1
  • This is the preferred treatment for more symptomatic presentations

Fluconazole-Refractory Disease

If symptoms persist despite fluconazole treatment:

  • Itraconazole solution 200 mg once daily OR posaconazole suspension 400 mg twice daily for 3 days, then 400 mg daily for up to 28 days 1
  • Alternative: Voriconazole 200 mg twice daily OR amphotericin B deoxycholate oral suspension 100 mg/mL four times daily 1
  • For truly refractory cases: IV echinocandin (caspofungin 70-mg loading dose, then 50 mg daily; micafungin 100 mg daily; or anidulafungin 200-mg loading dose, then 100 mg daily) 1

Special Considerations

  • Denture-related candidiasis requires disinfection of the denture in addition to antifungal therapy 1
  • For HIV-infected patients, antiretroviral therapy is strongly recommended to reduce recurrent infections 1
  • Chronic suppressive therapy is usually unnecessary, but if recurrent infections occur, fluconazole 100 mg three times weekly can be used 1

Vaginal Candidiasis (Vaginal Thrush)

Uncomplicated Vulvovaginal Candidiasis (90% of cases)

Single-dose oral therapy:

  • Fluconazole 150 mg as a single oral dose 2, 3

Topical intravaginal options (all equally effective):

  • Clotrimazole 1% cream 5 g intravaginally for 7-14 days 3
  • Clotrimazole 2% cream 5 g intravaginally for 3 days 3
  • Miconazole 2% cream 5 g intravaginally for 7 days 3
  • Miconazole 4% cream 5 g intravaginally for 3 days 3
  • Miconazole 200 mg suppository for 3 days 3
  • Terconazole 0.4% cream 5 g intravaginally for 7 days 3
  • Terconazole 0.8% cream 5 g intravaginally for 3 days 3

The choice between oral and topical therapy should be based on patient preference, as efficacy is equivalent. 2

Complicated Vulvovaginal Candidiasis (10% of cases)

Defined as: severe symptoms, recurrent disease (≥4 episodes/year), non-albicans species, or abnormal host (diabetes, immunosuppression, pregnancy)

  • Topical azole therapy for 7-14 days 2
  • Alternative: Fluconazole 150 mg every 72 hours for 3 doses 2

Recurrent Vulvovaginal Candidiasis (≥4 episodes/year)

Induction phase:

  • 10-14 days of topical or oral azole therapy 2

Maintenance phase:

  • Fluconazole 150 mg once weekly for 6 months 2, 4
  • Note: 50% of patients relapse after stopping maintenance therapy, so consider longer-term suppression in some cases 5

Non-Albicans Species

For C. glabrata (fluconazole-resistant):

  • Boric acid 600 mg vaginal suppository daily for 14 days 2
  • Alternative: Topical flucytosine cream (must be compounded) 2
  • Alternative: High-dose fluconazole 800 mg daily for 2-3 weeks (though resistance is common) 5

For C. krusei (triazole-resistant):

  • Amphotericin B deoxycholate 0.3-0.6 mg/kg daily 1

Common Pitfalls and Caveats

Diagnostic accuracy: Less than 50% of women who self-diagnose and treat for vaginal candidiasis actually have the condition. 3 Confirmation with microscopy, pH testing (should be <4.5), or culture is recommended before treatment when possible.

Pregnancy considerations:

  • For oral thrush: Topical agents are preferred; avoid systemic azoles
  • For vaginal candidiasis: Only topical azole therapy should be used; oral fluconazole is contraindicated 3
  • Treatment in third trimester may reduce neonatal oral thrush and diaper dermatitis 5

Partner treatment: Male sexual partners do not require treatment unless symptomatic 6

Resistance patterns: Azole-resistant C. albicans is extremely rare in vaginal candidiasis but more common in oral candidiasis, particularly in HIV-infected patients 2

Treatment failure: If symptoms persist after appropriate therapy, consider non-albicans species, reinfection, incorrect diagnosis (bacterial vaginosis, trichomoniasis, contact dermatitis), or rarely, true azole resistance requiring culture and susceptibility testing 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.